Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
about
sameAs
Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogsAcute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid eraHistone deacetylase inhibitors: insights into mechanisms of lethality.RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation.Assays for pharmacodynamic analysis of histone deacetylase inhibitors.Epigenetic regulation of normal and malignant hematopoiesis.Gemtuzumab ozogamicin for the treatment of acute promyelocytic leukemia: mechanisms of action and resistance, safety and efficacy.Transcriptional and epigenetic networks in haematological malignancy.Unlocking the potential of retinoic acid in anticancer therapy.A new transcriptional variant and small azurophilic granules in an acute promyelocytic leukemia case with NPM1/RARA fusion gene.Interstitial insertion of RARα gene into PML gene in a patient with acute promyelocytic leukemia (APL) lacking the classic t(15;17).Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia (APL)
P2860
Q26991440-7E39ED30-6685-47BA-B0F8-1C23B4793718Q35640734-EB2434C7-8F5C-46D3-9FE2-514AAE1376C6Q36219726-5744FF6B-436D-4AB9-AD2F-C4979E9E64BFQ36238093-46DC95A4-0807-4668-84A6-F8D1D58222CEQ36546255-411DF610-45E0-44A8-89D2-261E72DC6627Q36970179-45CC55EB-B80E-442F-B2F0-43BEAD453320Q37818248-995112A8-44B2-4C73-A4F3-F8A857BE1EA2Q37863271-190E401F-B064-451D-87A7-FDAA4A8B936FQ38269931-5BCA4FEA-929C-4620-82EB-F2F1B4BCDE39Q38581414-4328557A-21FF-4F63-8C12-086D795F4E03Q42878314-2F1185F9-5F8A-4655-92CD-EFCE5ECA32BDQ55362655-FFE858FE-AD20-497A-A2F8-5CEB88BF34B8Q57224260-53369A5F-3050-4671-B0E2-0E61A50A0026
P2860
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
@ast
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
@en
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
@nl
type
label
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
@ast
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
@en
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
@nl
prefLabel
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
@ast
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
@en
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
@nl
P2093
P1476
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
@en
P2093
Andres Sirulnik
Ari Melnick
Arthur Zelent
P304
P356
10.1016/S1521-6926(03)00062-8
P407
P577
2003-09-01T00:00:00Z